Clotrimazole PCD Pharma Franchise Company

Cafoli Lifecare offers a Clotrimazole range of 24 formulations across cream, dusting powder, ear drops, mouth wash, softgel and spray, manufactured in WHO-GMP certified facilities. Distributors building a dermatology and antifungal portfolio can secure district-wise monopoly franchise rights on this high-volume molecule.

What is Clotrimazole?

Clotrimazole is a broad-spectrum imidazole antifungal that inhibits ergosterol synthesis, disrupting the fungal cell membrane. It is effective against dermatophytes, yeasts and Candida across skin, mucosal and vaginal sites. It is listed on the WHO Model List of Essential Medicines. More information is on MedlinePlus.

Therapeutic Applications

Clotrimazole treats ringworm, athlete foot, candidiasis, vaginal yeast infection, oral thrush, otomycosis and pityriasis versicolor, in topical, vaginal, oral and otic forms. Prescribers include dermatologists, gynaecologists, ENT specialists and general physicians, with strong OTC movement as well.

Why Clotrimazole is a High-Potential Molecule for Distributors

India's hot, humid climate makes fungal skin infections one of the most frequent presentations at both clinics and pharmacies, with sharp monsoon spikes. Clotrimazole's breadth — creams, powders, drops and vaginal forms — lets a single franchise cover derma, gynae and ENT prescriptions plus heavy OTC counter demand, making it a reliable, fast-turnover volume driver.

Why Choose Cafoli Lifecare

Cafoli Lifecare is a WHO-GMP compliant, DCGI-approved PCD pharma company with 1000+ franchise partners across India. Partners receive district-wise monopoly rights, promotional inputs including visual aids, MR bags and product cards, and consistent stock availability backed by quality-tested manufacturing.

References

1. MedlinePlus: Clotrimazole
2. PubChem: Clotrimazole
3. WHO Model List of Essential Medicines